Literature DB >> 22043109

Manganese-based MRI contrast agents: past, present and future.

Dipanjan Pan1, Anne H Schmieder, Samuel A Wickline, Gregory M Lanza.   

Abstract

Paramagnetic and superparamagnetic metals are used as contrast materials for magnetic resonance (MR) based techniques. Lanthanide metal gadolinium (Gd) has been the most widely explored, predominant paramagnetic contrast agent until the discovery and association of the metal with nephrogenic systemic fibrosis (NSF), a rare but serious side effects in patients with renal or kidney problems. Manganese was one of the earliest reported examples of paramagnetic contrast material for MRI because of its efficient positive contrast enhancement. In this review, manganese based contrast agent approaches are discussed with a particular emphasis on their synthetic approaches. Both small molecules based typical blood pool contrast agents and more recently developed novel nanometer sized materials are reviewed focusing on a number of successful molecular imaging examples.

Entities:  

Year:  2011        PMID: 22043109      PMCID: PMC3203535          DOI: 10.1016/j.tet.2011.07.076

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  66 in total

1.  Manganese-enhanced magnetic resonance imaging (MEMRI).

Authors:  Cynthia A Massaad; Robia G Pautler
Journal:  Methods Mol Biol       Date:  2011

2.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.

Authors:  Hyon Bin Na; Jung Hee Lee; Kwangjin An; Yong Il Park; Mihyun Park; In Su Lee; Do-Hyun Nam; Sung Tae Kim; Seung-Hoon Kim; Sang-Wook Kim; Keun-Ho Lim; Ki-Soo Kim; Sun-Ok Kim; Taeghwan Hyeon
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

3.  Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis.

Authors:  W C Small; D D Macchi; J R Parker; M E Bernardino
Journal:  Acad Radiol       Date:  1998-04       Impact factor: 3.173

4.  Localization of 58Co and 65Zn-hematoporphyrin complexes in canine lymph nodes.

Authors:  R A Fawwaz; H S Winchell; F Frye; W Hemphill; J H Lawrence
Journal:  J Nucl Med       Date:  1969-09       Impact factor: 10.057

5.  Studies on poisonous metals. X. Metabolic fate of manganese after oral administration of excessive manganese chloride in rats.

Authors:  S Kojima; M Hirai; M Kiyozumi; Y Sasawa; M Nakagawa; T Shin-o
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-07       Impact factor: 1.645

6.  Convertible manganese contrast for molecular and cellular MRI.

Authors:  Erik M Shapiro; Alan P Koretsky
Journal:  Magn Reson Med       Date:  2008-08       Impact factor: 4.668

7.  Manganese-enhanced MRI of the rat visual pathway: acute neural toxicity, contrast enhancement, axon resolution, axonal transport, and clearance of Mn(2+).

Authors:  Marte Thuen; Martin Berry; Tina Bugge Pedersen; Pål Erik Goa; Mike Summerfield; Olav Haraldseth; Axel Sandvig; Christian Brekken
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

8.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Authors:  Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

Review 9.  Manganese exposure, essentiality & toxicity.

Authors:  A B Santamaria
Journal:  Indian J Med Res       Date:  2008-10       Impact factor: 2.375

10.  Safety and optimum concentration of a manganese chloride-based oral MR contrast agent.

Authors:  M E Bernardino; J C Weinreb; D G Mitchell; W C Small; M Morris
Journal:  J Magn Reson Imaging       Date:  1994 Nov-Dec       Impact factor: 4.813

View more
  58 in total

1.  Manganese.

Authors:  Michael Aschner; Keith Erikson
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 2.  Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.

Authors:  Xiaoxia Cai; Qingxia Zhu; Yun Zeng; Qi Zeng; Xueli Chen; Yonghua Zhan
Journal:  Int J Nanomedicine       Date:  2019-10-21

3.  Transition Metal Doping Reveals Link between Electron T1 Reduction and 13C Dynamic Nuclear Polarization Efficiency.

Authors:  Peter Niedbalski; Christopher Parish; Qing Wang; Zahra Hayati; Likai Song; André F Martins; A Dean Sherry; Lloyd Lumata
Journal:  J Phys Chem A       Date:  2017-11-21       Impact factor: 2.781

4.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

Review 5.  Targeted nanotechnology for cancer imaging.

Authors:  Randall Toy; Lisa Bauer; Christopher Hoimes; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2014-08-09       Impact factor: 15.470

Review 6.  Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Authors:  Joel Garcia; Stephen Z Liu; Angelique Y Louie
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-11-28       Impact factor: 4.226

Review 7.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

Review 8.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

9.  Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.

Authors:  Juan L Vivero-Escoto; William J Rieter; Honam Lau; Rachel C Huxford-Phillips; Wenbin Lin
Journal:  Small       Date:  2013-04-24       Impact factor: 13.281

10.  Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.

Authors:  Manli Song; Ting Liu; Changrong Shi; Xiangzhong Zhang; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2015-12-14       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.